A mutation in the γ2 subunit of the γ-aminobutyric acid (GABA) type A receptor (GABAR), which changes an arginine to a glutamine at position 43 (R43Q), is linked to familial idiopathic epilepsies. We used radioligand binding, immunoblotting, and immunofluorescence techniques to examine the properties of wild-type α1β2γ2 and mutant α1β2γ2R43Q GABARs expressed in HEK 293 cells. The γ2R43Q mutation had no affect on the binding affinity of the benzodiazepine flunitrazepam. However, in cells expressing α1β2γ2R43Q GABARs, the number of binding sites for [3H]flunitrazepam relative to wild-type receptors was decreased 75%. Using surface protein biotinylation, affinity purification, and immunoblotting, we demonstrated that expression of cell surface α1β2γ2R43Q GABARs was decreased. Surface immunostaining of HEK 293 cells expressing α1β2γ2R43Q GABARs confirmed that surface expression of the γ2R43Q subunit was reduced. These data demonstrate that the γ2R43Q mutation impairs expression of cell surface GABARs. A deficit in surface GABAR expression would reduce synaptic inhibition and result in neuronal hyperexcitability, which could explain why families possessing the γ2R43Q subunit have epilepsy.
A GABAA Receptor Mutation Linked to Human Epilepsy (γ2R43Q) Impairs Cell Surface Expression of αβγ Receptors*
Published 2004 in Journal of Biological Chemistry
ABSTRACT
PUBLICATION RECORD
- Publication year
2004
- Venue
Journal of Biological Chemistry
- Publication date
2004-11-05
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-25 of 25 references · Page 1 of 1
CITED BY
Showing 1-62 of 62 citing papers · Page 1 of 1